MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 DiabetesGlobeNewsWire • 11/06/23
MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023GlobeNewsWire • 10/31/23
Tyvaso DPI Is Breathing New Life Into MannKind's Balance Sheet (Rating Upgrade)Seeking Alpha • 10/18/23
Here's What Key Metrics Tell Us About MannKind (MNKD) Q2 EarningsZacks Investment Research • 08/07/23
MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare ConferenceGlobeNewsWire • 08/01/23
MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023GlobeNewsWire • 07/31/23
MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)GlobeNewsWire • 06/22/23
Governor Ned Lamont to Tour MannKind June 12 as It Reaches a Manufacturing MilestoneGlobeNewsWire • 06/11/23
Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical OfficerGlobeNewsWire • 05/24/23
MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/10/23
CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial ResultsGlobeNewsWire • 05/10/23